A public health action plan is needed for chronic kidney disease

Advances in Chronic Kidney Disease

Volumn 12, Issue 4, 2005, Pages 418-423

  Schoolwerth, Anton C ^a   Engelgau, Michael M ^a   Hostetter, Thomas H ^a  

^a NONE

Author keywords

End stage renal disease; Kidney disease; Outcomes; Prevention; Public health; Surveillance

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL;

CHRONIC KIDNEY DISEASE; DISEASE CLASSIFICATION; ECONOMIC ASPECT; ETHNOLOGY; HEALTH CARE PLANNING; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; RACE; REVIEW; RISK ASSESSMENT; TREATMENT FAILURE;

EID: 25444494945     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2005.07.012     Document Type: Article

References (49)

1. F. Vinicor Is diabetes a public-health disorder? Diabetes Care 17 suppl 1 1994 22 27
2. J.B. Saadine Vision loss A public health problem? Ophthalmology 110 2003 253 254
3. J. Coresh, B.C. Astor, T. Greene Prevalence of chronic kidney disease and decreased kidney function in the adult US population Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
4. US Renal Data System: USRDS 2002, 2003 and 2004 annual data reports. Atlas of end-stage renal disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002, 2003, 2004
5. C.J. Pirtle, A.C. Schoolwerth, W.H. Giles, D.W. Brown, A.H. Mokdad, E.S. Ford State-specific trends in chronic kidney disease-United States, 1990-2001 MMWR Morb Mortal Wkly Rep 53 2004 918 920
6. R.M. Merrill, L.G. Kessler, J.M. Udler Comparison of risk estimates for selected diseases and causes of death Prev Med 28 1999 179 193
7. B.A. Kiberd, C.M. Clase Cumulative risk for developing end-stage renal disease in the US population J Am Soc Nephrol 13 2002 1635 1644
8. J.L. Xue, J.Z. Ma, T.A. Louis Forecast of the number of patients with end-stage renal disease in the United States to the year 2010 J Am Soc Nephrol 12 2001 2753 2758
9. D. Gilbertson, C. Solid, J.L. Xue Projecting the US ESRD population by 2030 2003 US Renal Data System San Diego, CA Data presented at the 2003 American Society of Nephrology Annual Meeting, Available at: http://www.usrds.org/ presentations_2003.htm. Accessed August 10, 2005
10. N.S. Anavekar, J.J.V. McMurray, E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
11. A.S. Go, G.M. Chertow, D. Fan Chronic kidney disease and risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
12. V. Menon, M.J. Sarnak The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease A high-risk combination Am J Kidney Dis 45 2005 223 232
13. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease A statement from the councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology and epidemiology and prevention Circulation 108 2003 2154 2169
14. A.H. Mokdad, J.S. Marks, D.F. Stroup Actual causes of death in the United States, 2000 JAMA 291 2004 1238 1245
15. L.G. Hunsicker The consequences and costs of chronic kidney disease J Am Soc Nephrol 15 2004 1363 1364
16. D.H. Smith, C.M. Gullion, G. Nichols Cost of medical care from chronic kidney disease and comorbidity among enrollees in a large HMO population J Am Soc Nephrol 15 2004 1300 1306
17. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease Evaluation, classification and stratification Am J Kidney Dis 39 suppl 1 2002 S1 S266
18. P.E. de Jong, B.M. Brenner From secondary to primary prevention of progressive renal disease The case for screening for albuminuria Kidney Int 66 2004 2109 2118
19. American Diabetes Association Nephropathy in diabetes Diabetes Care 27 suppl 1 2004 S79 S83
20. G. Eknoyan, T. Hostetter, G.L. Bakris Proteinuria and other markers of chronic kidney disease A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Am J Kidney Dis 42 2003 617 622
21. L.E. Boulware, B.G. Jaar, M.E. Tarver-Carr Screening for proteinuria in US adults A cost-effectiveness analysis JAMA 290 2003 3101 3114
22. H.H. Parving, A.R. Andersen, U.M. Smidt Early aggressive antihypertensive treatment reduces the rate of decline in kidney function in diabetic nephropathy Lancet 1 1983 1175 1179
23. E.J. Lewis, L.G. Hunsicker, R.P. Bain The effect of angiotensin converting enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
24. G. Maschio, D. Alberti, G. Janin Effect of angiotensin converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
25. The Gruppo Italiano di Studi Epidemiologici in Nephrologia (GISEN) Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric non-diabetic nephropathy Lancet 349 1997 1857 1863
26. B.M. Brenner, M.E. Cooper, D. de Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
27. E.J. Lewis, L.G. Hunsicker, W.R. Clarke Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
28. M.T. Pedrini, A.S. Levey, J. Lau The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases A meta-analysis Ann Intern Med 124 1996 627 632
29. P. Ruggenenti, A. Perna, G. Remuzzi ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: a post hoc analysis of the REIN Trial results J Am Soc Nephrol 12 2001 2832 2837
30. S. Bianchi, R. Bigazzi, A. Caiazza A controlled prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Am J Kidney Dis 41 2003 565 570
31. E. Morales, A. Valero, M. Léon Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies Am J Kidney Dis 41 2001 319 327
32. H. Schiffl, S.M. Lang, R. Fischer Stopping smoking slows accelerated progression of renal failure in primary renal disease J Nephrol 15 2002 270 274
33. J.L. Xue, W.L. St. Peter, J.P. Ebben Anemia treatment in the pre-ESRD period and associated mortality in elderly patients Am J Kidney Dis 40 2002 1153 1161
34. C. Gouva, P. Nikolopoulos, J.P. Ioannidis Treating anemia early in renal failure patients slows the decline of renal function A randomized controlled trial Kidney Int 66 2004 753 760
35. H.L. Hillege, V. Fidler, G.F. Diercks Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 2002 1777 1782
36. J.S. Jensen, K. Borch-Johnsen, G. Jensen Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically health subjects Clin Sci (Colch) 88 1995 629 633
37. F.W. Asselbergs, G.F.H. Diercks, H.L. Hillege Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria Circulation 110 2004 2809 2816
38. E.R. Mathiesen, E. Hommel, H.P. Hansen Randomized-control trial of long-term efficacy of captopril on preservation of kidney function in normotensive patients with insulin-dependent diabetes and microalbuminuria BMJ 23 1999 1478 1485
39. Y. Lacourciere, A. Belanger, C. Godin Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy Kidney Int 58 2000 762 769
40. C.E. Mogensen Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria Diabetes 39 1990 761 767
41. R.G. Nelson, P.H. Bennet, G.J. Beck Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus N Engl J Med 335 1996 1636 1642
42. S.J. Pinto-Sietsma, W.M.T. Janssen, H.L. Hillege Urinary albumin excretion is associated with renal functional abnormalities in a non-diabetic population J Am Soc Nephrol 11 2000 1882 1888
43. W.M. McClellan, D.F. Knight, H. Karp Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients important differences between practice and published guidelines Am J Kidney Dis 29 1997 368 375
44. G.T. Obrador, R. Ruthazer, P. Arora Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States J Am Soc Nephrol 10 1999 1793 1800
45. A.R. Nissenson, A.J. Collins, J. Hurley Opportunities for improving the care of patients with chronic renal insufficiency Current practice patterns J Am Soc Nephrol 12 2001 1713 1720
46. J. Coresh, D. Byrd-Holt, B.C. Astor Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000 J Am Soc Nephrol 16 2005 180 188
47. A.S. Levey, J. Coresh, E. Balk National Kidney Foundation practice guidelines for chronic kidney disease Evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
48. T.F. Parker, R. Blantz, T. Hostetter Council of American Kidney Societies The chronic kidney disease initiative J Am Soc Nephrol 15 2004 708 716
49. T.H. Hostetter, M. Lising National Kidney Disease Education Program J Am Soc Nephrol 14 suppl 2 2003 S114 S116